Peptides DB
Research-centric peptide and protocol reference hub
Study 13 of 13Teriparatide (PTH 1-34) literatureAnnals of medicine · RCT2026

Comparison of ultrasound-guided two-point block of the rhomboid intercostal <i>vs.</i> thoracic paravertebral for postoperative analgesia in patients undergoing three-port thoracoscopic surgery: a prospective, randomized, non-inferiority study.

Ultrasound-guided two-point rhomboid intercostal block is non-inferior to thoracic paravertebral block for postoperative analgesia in thoracoscopic surgery, but may require more rescue analgesia.

Read at Annals of medicineAdd to compare

Where it sits

this study against the rest of the teriparatide (pth 1-34) corpus
0
Preclinical
11
Observational
0
Open-label
2
Randomised · this one
0
Reviews

Summary and findings

This study compared the analgesic efficacy of ultrasound-guided two-point rhomboid intercostal block (RIB) with that of two-point thoracic paravertebral block (TPVB) in patients undergoing three-port thoracoscopic surgery. Seventy patients were block-randomized to receive either TPVB or RIB, both using 10 mL of 0.5% ropivacaine. The primary outcome was the numerical rating scale (NRS) pain score at rest 24 hours after surgery.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Mean difference in resting NRS scores at 24 h was 0.088 (95% CI, -0.377 to 0.553).2026

Abstract

The authors’ words, as Annals of medicine supplied them

<h4>Background</h4>The anesthetic characteristics of ultrasound-guided two-point rhomboid intercostal block (RIB) have not been fully established. This study compared the analgesic efficacy of ultrasound-guided two-point RIB with that of two-point thoracic paravertebral block (TPVB) for postoperative pain control and recovery in patients undergoing three-port thoracoscopic surgery.<h4>Methods</h4>Seventy patients aged 18-80 years scheduled for three-port thoracoscopic pulmonary resection were block-randomized in a 1:1 ratio to receive either TPVB or RIB. Both techniques were performed using 10 mL of 0.5% ropivacaine at each injection site. The primary outcome was the numerical rating scale (NRS) pain score at rest 24 h after surgery, with a predefined non-inferiority margin of Δ = 1. Secondary outcomes included NRS at rest and during coughing at 0.5, 2, 4, 12, 18, 24, and 48 h postoperatively, as well as the 24h postoperative Quality of Recovery-40 (QoR-40) score.<h4>Results</h4>The final analysis included 34 patients in the TPVB group and 34 in the RIB group. The mean difference in resting NRS scores at 24 h between the two groups was 0.088 (95% CI, -0.377 to 0.553), confirming the non-inferiority of RIB. However, the need for rescue analgesia was numerically greater in the RIB group than in the TPVB group (<i>p</i> = 0.045). The 24-h postoperative QoR-40 scores and cumulative sufentanil consumption within 48 h after surgery were comparable between the groups (both <i>p</i> > 0.05).<h4>Conclusion</h4>Ultrasound-guided two-point RIB provided postoperative analgesia that was non-inferior to TPVB in patients undergoing three-port thoracoscopic surgery.

Elsewhere in the Teriparatide (PTH 1-34) corpus

BTransitions between contraceptive states among women aged 15-49 Years in Guinea.Public health in practice (Oxford, England) · 2026 · 61.1% probability of transitioning following pregnancy outcomes.HumanBOsteoporosis limits neurological recovery after spinal cord injury through PDGF-BB-MMP14 signalingbiorxiv-preprint · 2026 · Not reported in abstract.HumanBImpact of Preoperative Teriparatide Use on Proximal Junctional Kyphosis Prevention in Osteopenic/Osteoporotic Patients Undergoing Adult Spinal Deformity Surgery: A Propensity Score-Matched Studybiorxiv-preprint · 2026 · 44.2% PJK incidence in teriparatide group vs. 52.5% in non-teriparatide group, P = 0.426HumanBFragmented prevention in rural South Africa: a qualitative study of Biokineticists' perspectives on health system barriers to early detection of non-communicable diseases.Global health action · 2026 · n=10 · Not reported in abstract.HumanBFrom giant components to communities: community-level insights for prioritizing interventions within large clusters of HIV-1 transmission networks.Infectious Disease Modelling · 2026 · n=681 · 681 members in the giant component identified.reviewBPatients With Pancreatitis-Related Gene Variants Showed Higher Incidence of Hyperpancreatic Enzymemia After Endoscopic Retrograde Cholangiopancreatography.DEN open · 2023 · n=94 · Odds ratio for PEH in patients with PRG-variants was 6.291 (95% CI, 1.133-34.934).Human